Replies to post #101498 on Biotech Values

[DewDiligence]

ABT dumps EBS’ TRU-016 for CLL/NHL:

http://finance.yahoo.com/news/Emergent-Announces-Plans-TRU-bw-1979471110.html?x=0

EBS acquired this drug in the Aug 2010 buyout of Trubion.

[DewDiligence]

EBS acquires CNJ.TO for $3.24 (C$3.44)/sh in cash:

http://finance.yahoo.com/news/cangene-acquired-emergent-biosolutions-us-233900862.html

The nominal deal value is $222M; the buyout price is a 27% premium to yesterday’s close in Toronto (the shares did not trade today).